Insight
Managing Informed Consent Samples from Clinical Trials
Sample-level consent management is a critical component of clinical trials, especially follow-on and translational research. Best practice recommendations suggest that sponsors should use a configurable system to define a flexible and manageable set of attributes at the study, country, and site levels that can be applied to all samples collected over the duration of the trial.
Complete the form below to access this insight brief
Related Insights
Consent Tracking for Clinical Trial Samples
Optimizing the management of consents throughout the entire lifecycle
Tracking Clinical Trial Samples
Optimizing the management of samples throughout the entire lifecycle
Blockchain in Clinical Research Sample Management
Distributed Ledger Technology (DLT) in clinical trials
Managing Sample Data from Vendors
Best Practices for Clinical Trials
Using Labmatrix® at a Big Biopharma Company to Reduce Clinical Trial Delays, Costs and Regulatory Risks
Managing Sample Data from Vendors
Best practices for clinical trials
eConsent and BioBanking
How to reduce costs while improving efficiencies
Key Central Laboratory Capabilities to Enable Successful Immuno-Oncology Clinical Development
Trends and recommendations in laboratory selection
Best practices in clinical trial sample and consent lifecycle management
Clinical Trial Biospecimen and Consent Tracking
Learn about the BioFortis solution for addressing new challenges around sample and consent tracking
